Solopharm’s Post

Are billing issues cutting into your profits? Our specialized billing services for endocrinology and nephrology ensure accuracy and faster payments. Boost your revenue by 60% with MediCode. #MedicalBilling #Endocrinology #Nephrology #RevenueCycleManagement #Healthcare

An important study that should change how acromegaly (gigantism) is treated in the future. With 3 tests 78% of people achieve control vs 53% of traditional let's-see-if-it-works treatment. The three tests include one protocol that can be done in office (short acting octreotide test), one that depends on the MRI findings (T2 Magnetic Resonance), and one that must be done with pituitary tissue from surgery (E-cadherin). Based on testing, a determination is made if octreotide or lanreotide monotherapy, or pegvisomant monotherapy, or a combination would provide the best response. For cases with minor elevations of IGF1, cabergoline was also started at a dose of 1mg/wk combined with octreotide or lanreotide. Omar Nájera, MD Ameer Khowaja MD, M.Sc. (Public Health-HSM), CCD., FEAA. Martha Bilbatua Robin Pitzer #neendocrinology #evidencebasedmedicine #acromegaly #gigantism MedPage Today Endocrine Society #endocrinology

https://lnkd.in/gRNTpKGa Article title: Normal tension glaucoma: Prevalence, etiology and treatment   Author(s): George Ayoub*; Yanan Luo; Dominic Man-Kit Lam   Journal: Journal of Clinical Research and Ophthalmology   Journal ISSN: 2455-1414 Abstract: Normal tension glaucoma is the most common type of glaucoma among people of east Asian countries. While a significant minority of cases of normal tension glaucoma respond to drugs or surgical procedures that lower intra-ocular pressure, most cases continue to progress, resulting in a continuing loss of visual field and blindness. We here review the current state of knowledge of this debilitating disease, and evaluate a promising pilot study showing a potential route to evaluate normal tension glaucoma and to effectively treat it with a vitamin and mineral supplement. #OphthalmologySubspecialties #Optometry #VisualScience #PharmacologyInEyeDiseases #BasicSciences #PrimaryEyeCare #SecondaryEyeCare #PatientSafety #QualityImprovements #NeuroOphthalmology #MedicalEyeCare #SurgicalEyeCare #GlaucomaFilteringProcedure #OcularDrugDesign #ClinicalPsychophysics #DiabeticRetinopathy #CataractSurgery #RefractiveSurgery #PVRStudies #LowVision #PterygiaStudies #PupilLightReflex #Peertechz #PeertechzPublications #SecondaryCataractStudies #RetinalDiseases #RetinalSurgery #SubstancePStudies #Cornea #ExternalEyeDisease #DefensinsForCorneaTransplants #CraniofacialClinic #OptometryClinic #OphthalmicGeneticsClinic #NeuroOphthalmologyClinic #Oculoplastics #TearingDisordersClinic #PediatricRetinaClinic #CornealNeovascularization #ImmunologicalMechanisms #MolecularMechanisms #LaserTherapyInOphthalmology #ImagingInOphthalmology #OcularImmunology #VisionAndOphthalmology #NeuroOphthalmology

People with Natural 👩🏻🦰Red Hair May Be More Sensitive to Pain! Did you know Scotland has the highest concentration of redheads at 13%, followed by Ireland at 10%? 🌍Worldwide, only 2% of people have red hair. Redheads are often more sensitive to pain due to a gene mutation affecting pain receptors, meaning they usually need more anesthesia for dental and medical procedures. 🔬Since the early 2000s, studies on redheads' pain sensitivity have yielded mixed results. A 2004 Anesthesiology article found that those with the MC1R gene mutation needed up to 20% more anesthesia. Subsequent research found no clear link. A 2020 study suggested pain sensitivity and red hair may involve separate genetic factors. 🔥Our new post on the DrugCard platform blog explores recent findings and the role of #pharmacovigilance in understanding redheads' medication responses. 👉: https://lnkd.in/d7cp943F #drugsafety #patientsafety

Nearly half of the brain MRI scans performed in pediatric endocrinology patients are unnecessary, with repeated imaging often providing no new clinical insights, according to a study that emphasizes the need for clearer guidelines to reduce the overuse of MRIs. View the complete article below ⤵️ #GrowthHormone #GrowthHormoneDeficiency #PediatricEndocrinology #MRI

Having a hard time understanding MEN - Multiple Endocrine Neoplasia? Just tune into this insightful video by our pathology expert, Dr. Ranjana. Download Manipal MedAce for more expert-led videos like this. https://lnkd.in/gQmAPe-N [Pathology, MultipleEndocrineNeoplasia, Endocrinology, MedicalEducation, ManipalMedAce, MENsyndrome]

🌟 Announcing the Launch of Share of Voice Study: Wave 2 2024 🌟 We are excited to kick off the second wave of our Share of Voice study in 2024, expanding insights across cardiology, endocrinology, nephrology, respiratory and more! 📊 If you're interested in learning how your company scores among different specialists and would like to purchase these valuable insights, don’t hesitate to reach out. Let's dive deeper into the voices that shape healthcare! 💡 Contact us today to secure your copy of the study and uncover strategic insights into your market. #HealthcareInsights #ShareOfVoice #Cardiology #Endocrinology #Nephrology #MarketResearch #HealthcareMarketing #SOVStudy

It is our great pleasure to share Anna Bollinger’s latest publication “Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report.” Understanding a patient’s family health history (FHH) is crucial in clinical practice, however, it is often overlooked as it relies on subjective, self-reported information. Could pharmacogenetic (PGx) testing bridge this gap and validate self-reported drug-related problems (DRP) in FHH? This case study involving the genotyping of 10 family members of three generations demonstrates its potential: A nine-year-old girl underwent a preemptive PGx panel test before surgery due to her grandmothers’ self-reported DRPs in a perioperative context. PGx testing identified the girl as a CYP2B6 intermediate metabolizer with reduced enzyme activity and a CYP2D6 poor metabolizer with no enzyme activity, from which therapeutic recommendations for analgesia and anesthesia were deduced. However, the genotype-predicted phenotypes could not be traced back to the grandmothers. This case study illustrates how PGx testing can validate self-reported FHH. Additionally, the preemptive PGx testing results were used to inform perioperative treatment decisions by the anesthesiologist. Curious to read more? 🧐 Follow the link: https://lnkd.in/ezMupB6c #publication #PGx #FHH #DRP

What are the costs of #medications for #patients with #erectiledysfunction who are treated with PDE-5 inhibitors? Our resident, Ellen Cahill, MD, sits down with Urology Times to discuss the background and notable findings from the study "Trends in Phosphodiesterase Type 5 Inhibitor #Prescriptions and Cost: #Medicare Analysis 2017-2021." Read or watch the interview to learn more ⬇ Yale School of Medicine | MJH Life Sciences® | Piruz Motamedinia, MD | Michelle Ross

Current clinical management of obesity involves surgery to reduce stomach size or bypass part of the intestine. A new study on mice shows that shortening the length of microvilli in the jejunum can similarly shrink the surface area in the gut and thus limit the absorption of fat, potentially reducing the need for bariatric surgery for long-term weight loss. Authors showed that suppression of the DMV–vagus–jejunum axis controls intestinal fat absorption by shortening the length of microvilli and illustrate the therapeutic potential of puerarin binding to GABRA1 in fat loss. #ObesityResearch #BrainGutAxis #FatAbsorption #KudzuRoot #Puerarin #WeightLoss #GutHealth #Neuroscience #AntiObesityDrugs #IntestinalHealth #Microvilli #VagusNerve #MetabolicHealth #TraditionalMedicine #HealthInnovation #gastroenterology